Stock Taper 
BELLEVUE GROUP AG
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Seaport Therapeutics, Inc. Common Stock | SPTX | 1.1M | $23.89M |
 Aura Biosciences, Inc. | AURA | 1.17M | $8.28M |
 BridgeBio Pharma, Inc. | BBIO | 1.19M | $88.59M |
 Monte Rosa Therapeutics, Inc. | GLUE | 1.19M | $28.8M |
 Celldex Therapeutics, Inc. | CLDX | 1.2M | $44.65M |
 Avalyn Pharma Inc. Common Stock | AVLN | 1.35M | $44.44M |
 Insmed Incorporated | INSM | 1.39M | $148.57M |
 Enliven Therapeutics, Inc. | ELVN | 1.49M | $75.62M |
 Oruka Therapeutics, Inc. | ORKA | 1.66M | $157.71M |
 Vera Therapeutics, Inc. | VERA | 1.71M | $73.41M |
 Vaxcyte, Inc. | PCVX | 1.97M | $114.63M |
 Ultragenyx Pharmaceutical Inc. | RARE | 1.98M | $66.2M |
 Gilead Sciences, Inc. | GILD | 2.16M | $272.74M |
 Scholar Rock Holding Corporation | SRRK | 2.45M | $134.73M |
 Crinetics Pharmaceuticals, Inc. | CRNX | 2.62M | $98.04M |
 Immunocore Holdings plc | IMCR | 2.79M | $88.53M |
 Jade Biosciences, Inc. | JBIO | 3.06M | $67.95M |
 Relay Therapeutics, Inc. | RLAY | 6.19M | $115.74M |
 Viridian Therapeutics, Inc. | VRDN | 6.73M | $123.67M |